Market News AIOpen the app

LKFT stock news · Lakefront Biotherapeutics NV

Stories about Lakefront Biotherapeutics NV (LKFT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LKFT

Follow Lakefront Biotherapeutics NV (LKFT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LKFT
Free on the App Store and Google Play, or on the web.
  1. Sep 23, 2026, 2:38 PM ET · Market

    Crude oil prices go up by 1%, and Cintas made more money than people thought.

    Good for LKFT

    Lakefront Biotherapeutics shares rose after an analyst upgrade and a higher price target. The analyst upgrade pushed the stock higher and signals renewed investor interest.

  2. Sep 23, 2026, 10:10 AM ET · Market

    TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine, and other big stocks climbed on Wednesday.

    Good for LKFT

    Lakefront Biotherapeutics was upgraded by RBC Capital and its price target was raised from $26 to $45, which signals stronger analyst support for the company's outlook.

  3. Sep 23, 2026, 9:29 AM ET · Opinion

    An analyst is feeling positive about Editas Medicine and shares four company upgrades for Wednesday.

    Good for LKFT

    RBC raised Lakefront Biotherapeutics to Outperform and lifted the price target to $45, which raises analyst optimism for the company.